Cargando…

Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma

Detalles Bibliográficos
Autores principales: Araki, Yoshihiro, Yamamoto, Norio, Hayashi, Katsuhiro, Takeuchi, Akihiko, Miwa, Shinji, Igarashi, Kentaro, Higuchi, Takashi, Abe, Kensaku, Taniguchi, Yuta, Yonezawa, Hirotaka, Morinaga, Sei, Asano, Yohei, Ikeda, Hiroko, Nojima, Takayuki, Tsuchiya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055875/
https://www.ncbi.nlm.nih.gov/pubmed/33875768
http://dx.doi.org/10.1038/s41598-021-88629-2
_version_ 1783680531056033792
author Araki, Yoshihiro
Yamamoto, Norio
Hayashi, Katsuhiro
Takeuchi, Akihiko
Miwa, Shinji
Igarashi, Kentaro
Higuchi, Takashi
Abe, Kensaku
Taniguchi, Yuta
Yonezawa, Hirotaka
Morinaga, Sei
Asano, Yohei
Ikeda, Hiroko
Nojima, Takayuki
Tsuchiya, Hiroyuki
author_facet Araki, Yoshihiro
Yamamoto, Norio
Hayashi, Katsuhiro
Takeuchi, Akihiko
Miwa, Shinji
Igarashi, Kentaro
Higuchi, Takashi
Abe, Kensaku
Taniguchi, Yuta
Yonezawa, Hirotaka
Morinaga, Sei
Asano, Yohei
Ikeda, Hiroko
Nojima, Takayuki
Tsuchiya, Hiroyuki
author_sort Araki, Yoshihiro
collection PubMed
description
format Online
Article
Text
id pubmed-8055875
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80558752021-04-22 Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma Araki, Yoshihiro Yamamoto, Norio Hayashi, Katsuhiro Takeuchi, Akihiko Miwa, Shinji Igarashi, Kentaro Higuchi, Takashi Abe, Kensaku Taniguchi, Yuta Yonezawa, Hirotaka Morinaga, Sei Asano, Yohei Ikeda, Hiroko Nojima, Takayuki Tsuchiya, Hiroyuki Sci Rep Author Correction Nature Publishing Group UK 2021-04-19 /pmc/articles/PMC8055875/ /pubmed/33875768 http://dx.doi.org/10.1038/s41598-021-88629-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Araki, Yoshihiro
Yamamoto, Norio
Hayashi, Katsuhiro
Takeuchi, Akihiko
Miwa, Shinji
Igarashi, Kentaro
Higuchi, Takashi
Abe, Kensaku
Taniguchi, Yuta
Yonezawa, Hirotaka
Morinaga, Sei
Asano, Yohei
Ikeda, Hiroko
Nojima, Takayuki
Tsuchiya, Hiroyuki
Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
title Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
title_full Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
title_fullStr Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
title_full_unstemmed Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
title_short Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
title_sort author correction: the number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055875/
https://www.ncbi.nlm.nih.gov/pubmed/33875768
http://dx.doi.org/10.1038/s41598-021-88629-2
work_keys_str_mv AT arakiyoshihiro authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT yamamotonorio authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT hayashikatsuhiro authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT takeuchiakihiko authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT miwashinji authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT igarashikentaro authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT higuchitakashi authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT abekensaku authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT taniguchiyuta authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT yonezawahirotaka authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT morinagasei authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT asanoyohei authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT ikedahiroko authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT nojimatakayuki authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma
AT tsuchiyahiroyuki authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma